MedPath

Improving Decision Making for Patients With Prolonged Mechanical Ventilation

Not Applicable
Completed
Conditions
Prolonged Mechanical Ventilation
Surrogate Decision Makers
Interventions
Other: Usual care
Behavioral: Decision aid
Registration Number
NCT01751061
Lead Sponsor
Duke University
Brief Summary

Deciding about prolonged life support for critically ill patients can be very difficult. Therefore, the investigators are doing a study to see if an internet-based decision aid can improve the quality of decision making for substitute decision makers of patients who are in the intensive care unit (ICU).

Detailed Description

The process of making a decision about whether or not to provide prolonged life support is seriously deficient among clinicians and the surrogate decision makers for critically ill patients. To address this problem, we propose a randomized, controlled trial to determine if an innovative web-based decision aid compared to usual care control can improve the quality of decision making (defined as clinician-surrogate concordance for prognosis, quality of communication, and medical comprehension), reduce surrogates' psychological distress (depression, anxiety, and post-traumatic stress syndrome disorder (PTSD) symptoms), and reduce patients' health care costs over 6-month follow up. We will enroll 410 surrogate decision makers for 273 patients (expected average of 1.5 surrogates per patient). This study has the potential both to improve how clinicians and surrogates interact in intensive care units and to increase the likelihood that life support decisions are aligned with patients' values.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
416
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Usual careUsual careusual care in an intensive care unit setting
Decision aidDecision aidWeb-based decision aid (decision support tool) provided to surrogate decision maker
Primary Outcome Measures
NameTimeMethod
Change in Clinician-surrogate Concordance Scale Score~2-7 days post-randomization

Concordance is calculated as the absolute value of the difference in prognosis for 1 year patient survival between the surrogate(s) and the clinician (ICU physician), and, therefore, can range from 0 to 100.

We report pre-intervention to post-intervention difference in the CSCS.

The CSCS is calculated as the absolute value of the difference between the surrogate's response and that of either the treating ICU physician (primary outcome) or the nurse (secondary outcome) to the question, "What percent chance do you think \[the patient/your loved one\] has of being alive 1 year from now if the current treatment plan is continued?" Scores can range from 0 to 100 percentage points, and higher values indicate greater discordance.

Secondary Outcome Measures
NameTimeMethod
Post-traumatic Stress Syndrome InventoryPre-randomization (study day 1) and 180 days post-randomization

Here we report PTSS score differences between Interview 1 (baseline) and Interview 4 (6 months post-randomization) for primary (not secondary) surrogate decision makers.

PTSS scores can range from 10-70, with greater scores=more distress.

Patient-centeredness of Care ScaleStudy day 1 and 180 days post-randomization

Here we report change in patient-centeredness score between Study day 1 (Interview 1) and 180 days post-randomization (Interview 4) for primary (not secondary) surrogate decision makers.

Scores can range from 12-48 points, with higher scores=greater patient-centeredness.

Quality of Communication Scale ScoreStudy day 1 (pre-randomization), ~2-7

Here we report QOC score differences between Interview 1 (baseline) and Interview 2 (immediately post-intervention) for primary (not secondary) surrogate decision makers.

Scores range from 0-110, with higher scores=better quality of communication.

Medical Comprehension Scale ScoreStudy day 1 (pre-randomization), ~2-7

Here we report MCS score differences between Interview 1 (baseline) and Interview 2 (immediately post-intervention) for primary (not secondary) surrogate decision makers.

Scores can range from 0-8, with greater scores=better comprehension.

Hospital Anxiety and Depression Scale (HADS) Total ScorePre-randomization (study day 1) and 180 days post-randomization

We report here the difference between Interview 1 (baseline) and Interview 4 (6 months post-randomization) for primary surrogate decision makers (not secondary).

HADS scores can range from 0 to 42 points; higher scores=more distress.

Change in Clinical-surrogate Concordance Scale Score (Nurse)~2-7 days post-randomization

Concordance is calculated as the absolute value of the difference in prognosis for 1 year patient survival between the primary surrogate decision maker and the IUC nurse, and, therefore, can range from 0 to 100.

We report pre-intervention to post-intervention difference in the CSCS.

The CSCS is calculated as the absolute value of the difference between the surrogate's response and that of the nurse to the question, "What percent chance do you think \[the patient/your loved one\] has of being alive 1 year from now if the current treatment plan is continued?" Scores can range from 0 to 100 percentage points, and higher values indicate greater discordance.

Trial Locations

Locations (4)

University of North Carolina

🇺🇸

Chapel Hill, North Carolina, United States

University of Pittsburgh

🇺🇸

Pittsburgh, Pennsylvania, United States

Duke University

🇺🇸

Durham, North Carolina, United States

University of Washington

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath